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Abstract  
Background. The Human Papillomavirus (HPV) is a causative agent for the development of 
cancer which is a public health concern worldwide. In the United States (US), the highest 
incidence of cervical cancer is among Hispanics/Latinos. Although Hispanics/Latinos show the 
highest utilization rate of HPV vaccine, in general, the vaccination rates are still behind the 
Healthy People 2020 goal of 80%. The knowledge about this virus has been found low or non-
existent among most populations in the US, especially among minorities and populations with 
lower education and socioeconomic status. The knowledge and beliefs of Hispanic/Latin mothers 
about HPV and HPV vaccination are important for preventing the virus among adolescents. 
However, studies have shown a low knowledge of HPV and HPV vaccination among mothers of 
Hispanic/Latin origin.  
Aims. This research project aimed to assess the HPV vaccination knowledge, awareness and 
beliefs of mothers of Mexican origin living in the Midwest of the US who have adolescent 
children in the 9-18 years age range regardless of gender.  
Methods. A cross-sectional study was conducted among 100 mothers of Mexican origin living in 
Nebraska and neighboring states. Based on questionnaires used in previous studies, using 
structured questions a bilingual 76-item survey was developed for this study. Prospective 
participants were identified, and verbal consent was obtained before administering the survey. 
For the statistical analysis, the Statistical Package for the Social Sciences (SPSS) version 23.0 
was used. General descriptive statistics, contingency tables using Pearson Chi-squared test and a 
logistic regression model (LRM) were utilized. 
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Results. A total of 100 adult mothers of Mexican origin that were present in the Mexican 
Consulate between May and July of 2017 were recruited for the study. This was made possible 
by the partnership of the University of Nebraska Medical Center with OneWorld Community 
Health Centers and the Mexican Consulate in Omaha. From total mothers interviewed, only 36% 
of them indicated that their oldest adolescent in the desired age range had at least one dose of the 
HPV vaccine series. The knowledge about HPV and HPV vaccination was found mostly poor 
among participants. This result agrees with previous studies developed among Hispanic/Latin 
women in other regions. A regression model indicated that the HPV and HPV vaccination level 
of knowledge among the participants is a strong predictor of mothers giving the HPV vaccine to 
their adolescents.  
Keywords: HPV, knowledge, beliefs, vaccination, Hispanic/Latinos Health, minorities. 
Introduction 
The Human Papillomavirus (HPV) is a causative agent for the development of cancer which is a 
public health concern worldwide (Forman et al., 2012; Wilson et al., 2016). Being the most 
common sexually transmitted infection (STI) in the US, HPV has currently infected about 79 
million Americans, and another 14 million Americans become newly infected every year (CDC, 
2017a).  According to data from 2009 to 2013, approximately 39,800 HPV-associated cancers 
occur in the US each year, the most frequent type of cancers associated to the virus includes 
cervical, anal, vaginal, vulvar, penile and recent studies have established a link between HPV 
and oropharynx cancers (CDC, 2017c). 
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More than 40 types of HPV have been identified, some of them are responsible for cancer and 
others are responsible for genital warts (Saraiya, Dunne, Stokley, Middleman, & Markowitz, 
2013). Infection with HPV 16 and HPV 18 strains are responsible for most cases of cervical 
cancer (Chapman & Harris, 2016) while HPV 6 and HPV 11 strains are more commonly 
associated with genital warts which is a sexually transmitted benign condition (Forman et al., 
2012). HPV infection is the main risk factor associated with cervical cancer (Forman et al., 
2012). Persistent infections with one out of twelve HPV strains are responsible for all cases of 
cervical cancer (Schiffman et al., 2011). Based on previous research, a woman must be infected 
with any type of HPV before she develops cancer (American Cancer Society, 2016). Worldwide, 
the contribution of HPV 18 and HPV 16 strains for adenocarcinoma is 82% (de Sanjose et al., 
2010). 
In the US the vaccine to prevent HPV and its associated morbidity and mortality was publicly 
introduced in 2006. Several variations of the vaccine protect against an increasing number of 
HPV types (Galbraith et al., 2016; Handler, Handler, Majewski, & Schwartz, 2015; Saraiya et 
al., 2015).  Currently, Gardasil and Gardasil 9 are the HPV vaccines approved by the US Food 
and Drug Administration (FDA) to be administered to all genders. Gardasil prevents against four 
HPV types (6,11,16,18) and Gardasil 9 prevents against 9 of the most common cervical cancer-
causing agents worldwide (6,11,16,18, 31, 33, 45, 52, and 58) (Merck Newsroom Home, 2017). 
Some of the leading cancers prevented with the vaccine are cervical cancer (66.2%), anal cancer 
(79.4%), oropharyngeal cancer (60.2%), vaginal cancer (55.1%) and vulvar cancer (48.6%) 
(Saraiya et al., 2015).   
 
HPV vaccines are recommended for preteen girls and boys to protect against HPV infection 
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before they get exposed to the virus (CDC, 2017a). After 2016, the Centers for Disease Control 
and Prevention (CDC) recommends that all preteens who are 11 or 12 years old get the two-
dosage series of the HPV vaccine (CDC, 2017a; Galbraith et al., 2016). In the US about 65% of 
girls and 56% of boys have started the HPV vaccination series but still many children are not 
completing the series (CDC, 2016). In Nebraska and Iowa, the HPV vaccination coverage among 
adolescents 13-17 years old is 67.3% and 66.7%, respectively (CDC, 2017b).  Currently, many 
private health plans cover the cost of the HPV vaccine. However, if children and adolescents 18 
years of age or younger are either Medicaid eligible, Native American/Alaskan Native, uninsured 
or if their health insurance does not fully cover vaccines, they can get the HPV vaccine at no cost 
through the Vaccines for Children (VFC) Program (CDC, 2017d; Merck, 2017). 
 
Hispanics are the fastest-growing minority group in the US, representing about 17% of the total 
US population.  About 65% of the Hispanic population in the US are of Mexican origin (U.S. 
Census Bureau, 2016). In Nebraska, around 10.7% of total population are of Hispanic origin and 
in Iowa is around 5.8%.  Hispanics have a larger proportion of young people and a smaller 
proportion of older people.  Additionally, most of the Hispanic population living in Nebraska and 
Iowa are of Mexican origin, representing about 78% of all Hispanic/Latinos living in these states 
(CensUSgov., 2017)  
 
Hispanic women in the US have higher rates of cervical cancer than women in other racial or 
ethnic groups according to data compiled between 1999 and 2014 (CDC, 2017c). Additionally, 
this minority group tends to present severe cases of cervical cancer and higher mortality rates 
when compared to other racial groups (Mann, Foley, Tanner, Sun, & Rhodes, 2015).  Even 
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though in the US, HPV vaccine completion rates are higher for Latinas (72.8%) than for non-
Hispanic whites (70.6%), HPV vaccination rates continue below other recommended vaccines 
and below the Healthy People 2020 vaccination goal of 80% (Galbraith et al., 2016) 
 
Even though HPV is not rare, the knowledge about this virus has been found low or non-existent 
among most populations in the US, especially among minorities and populations with lower 
education and socioeconomic status (Fernandez et al., 2009). Previous studies have documented 
low levels of awareness and knowledge about HPV and the HPV vaccine among 
Hispanics/Latinos. In Utah, a study was conducted to explore factors related to the HPV vaccine 
knowledge, interest, and uptake among Hispanics/Latinos and results indicated that participants, 
71,2% of which were of Mexican origin, had limited knowledge about the HPV vaccine (Kepka, 
Warner, Kinney, Spigarelli, & Mooney, 2015). Similarly, a study conducted on the Texas-
Mexico border indicated that the understanding of HPV role in the etiology of cervical cancer is 
limited among Hispanics (Fernandez et al., 2009). Among Puerto Rican mothers and adolescents, 
research was conducted in 2014 and results indicated that women's knowledge about HPV and 
HPV vaccination was low, especially among mothers (CDC, 2015).  
 
Considering the above figures and the identified knowledge gaps in Hispanic/Latino, the aim of 
the present research project was to assess the HPV vaccination knowledge, awareness and beliefs 
of mothers of Mexican origin living in the Midwest who have adolescents in the 9-18 years age 
range and predict factors associated with the mothers’ willingness to vaccinate their children 
against HPV.  
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Methods 
Study design 
A cross-sectional survey was conducted between May and July of 2017 to understand how does 
a mothers’ willingness to give the HPV vaccine to their children relate to the knowledge about 
HPV vaccination among mothers. The recruitment of 100 adult mothers of Mexican origin that 
were present in the waiting room of the Mexican Consulate between May and July of 2017 was 
possible by the partnership of the University of Nebraska Medical Center with OneWorld 
Community Health Centers and the Mexican Consulate at Omaha. 
Study Site 
The Mexican consulate at Omaha provides services mostly to Mexican citizens living or 
traveling in the US who need assistance with US laws and legal system issues. The office in 
Omaha issues Mexican passports, officially stamps and notarizes legal documents to be used in 
Mexico and distributes information about the protection of Mexicans in the US.  Additionally, 
OneWorld community Health Centers provides health services and health education at the Health 
Window located inside the Mexican consulate.  
The Mexican consulate in Omaha is the closest office for Mexicans living in Nebraska and 
Iowa.  For the research recruitment purposes, the consulate and the Health Window operated by 
OneWorld Community Health Centers was an ideal place due to the diversity of participants 
from Nebraska, Iowa, and Kansas. 
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Sample 
To be eligible for study participation, respondents needed to be female, mother of Mexican 
origin living in Nebraska or a neighboring state, be at least 19 years or older, have a daughter or 
son, or daughter and son between 9 and 18 years of age living with her. It was included 9 years 
of age as a minimum because the HPV vaccine is approved for use after this age. The initial 
inclusion criteria included mothers from Nebraska only, but after the pilot testing of the 
questionnaire in the Mexican Consulate it was necessary to adjust it to include participants from 
other states that are frequently served by the Mexican Consulate in Omaha.  
Prospective participants were identified and once the inclusion criteria was met, the principal 
investigator of the study proceeded to explain the details of the study and ask for their verbal 
consent to administer the survey. 
A total of 132 potential participants were approached between June 17th and July 28th of 2017. 
A total of 100 participants agreed with verbal consent and participated in the survey. Of the 
approached people that met the inclusion criteria 24% refused to participate in the survey 
because of not having time or interest on the research. Anonymity was guaranteed at all times.  
Data collection  
Based on questionnaires used in previous studies on different populations (Allen et al., 2010; 
Cates, Brewer, Fazekas, Mitchell, & Smith, 2009; Davis, Dickman, Ferris, & Dias, 2004; 
Fazekas, Brewer, & Smith, 2008; Fuchs, Rahman, & Berenson, 2016; Kepka et al., 2015; Strohl 
et al., 2015) and surveys that assessed the Hispanic population (Allen et al., 2010; Fuchs, 
Rahman, & Berenson, 2016; Kepka et al., 2015;) a bilingual (English and Spanish) 76-item 
survey using structured questions was adapted for this study and administered to participants that 
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met the inclusion criteria after obtaining their oral consent (Appendix 1). English and Spanish 
equivalency in the survey was obtained by back-translating the English version to Spanish and 
vice versa, performed by bilingual personnel of the research project.  
All surveys were conducted by the principal investigator as an interview to guarantee the quality 
of the data collection. After the completion of the survey, information and educational material 
on HPV and HPV vaccine from the CDC as well as a 5 dollars gift card were given to 
participants. 
Research questionnaire  
The questionnaire had four main sections. The first part included demographic characteristics of 
the mother such as age, number of people in the household, current marital status, age at 
immigration, level of education, etc. The second part included demographic characteristics of 
child/children, including the number of children in the 9-18 age range living with them. The third 
part included questions assessing the mothers’ experience and satisfaction with received medical 
care for themselves and their children. The last section included questions related to the 
knowledge, awareness, beliefs and experience dealing with HPV and the HPV vaccine. 
Data Analysis and management 
Scoring 
HPV and HPV vaccination knowledge among respondents was assessed by respondents' 
affirmation or negation of 16 statements. These statements were related to how common is the 
HPV, perception of risk, detection, transmission, prevention, treatment and possible 
consequences of HPV infection. The answers to 14 statements were classified as: yes, no, and I 
do not know, and two questions were of multiple choice option. One point was assigned for 
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correct answers to the first 15 questions and three points were assigned to the last question for 
which more than one answer was allowed. The maximum total score possible was 19 points. The 
level of knowledge was assessed by adding the points obtained in the answers for the items. The 
total score was divided into three categories according to the percentiles 75th, 50th and 25th: high 
(15 or more points), medium (from 9 to 14 points) and low (8 or less points). Due to low 
frequency in the results for the high level of knowledge, we used two separate categories for 
level of knowledge: poor (score less than 8 points) and good (score more than 9 points). The 
binary results for level of knowledge (poor or good) permitted testing the knowledge of HPV 
vaccination against other variables using Chi-Square and regression analysis. 
HPV vaccination beliefs were assessed by the answers of 13 statements. Each statement asked 
about the importance, need, and benefits of vaccinating children in general. In addition, 
participants were asked about the benefits, safety, and appropriateness of HPV vaccination for 
children ages 9-12 years old. Beliefs about adverse behavioral consequences of HPV vaccination 
were assessed by the answer of two questions in the scale of Linkert. The two questions asked if 
vaccinating their children would send either of these messages: one, it is okay to have sex and 
two, she/he does not have to use safe sex practices. 
Questions assessing HPV and HPV vaccine awareness were also administered. Participants were 
asked if they had ever heard of HPV, the HPV vaccine and the sources of the information that 
included radio, TV, medical provider, relatives, friends or school. 
Data analysis 
The data analysis was performed by providing general descriptive statistics.  Contingency tables 
using Pearson Chi-squared were used to establish association between demographic 
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characteristics of participants and their specific HPV and HPV vaccination knowledge, 
awareness and vaccination status of their children.   A logistic regression model (LRM) was 
applied to identify the possible association between the level of knowledge about HPV and HPV 
vaccination among mothers and the vaccination status of their children; the model was adjusted 
by length of time in the USA, the age of the mother, health insurance status, HPV/HPV 
Vaccination Knowledge and level of education of the mother. For the statistical analysis, the 
Statistical Package for the Social Sciences (SPSS) version 23.0 was used.  
This research was approved by the University of Nebraska Medical Center Institutional Review 
Board (IRB).  
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Results 
Socio-demographic characteristics of mothers 
The mean age of the mothers was 40.76 years, with a standard deviation of 6.2. Most of the 
women interviewed had a basic level of education (up to nine years). The majority had a stable 
sexual partner, married or cohabiting (70%) and half were dedicated to housework. 
Characteristics of the study population are shown in Table 1. 
Table 1.  Socio-demographic characteristics of mothers (N=100) 
Variable % P-value 
Age   
27-37 29  
38-48 61  
49-59 10  
State of residence   
Nebraska 69  
Iowa 29  
Kansas 2  
Marital Status   
Married 57  
Single 13  
Co-habiting 23  
Other 7  
Country of origin of partner (N=80)  
Mexico 88  
United States 11  
Other 1  
Highest grade of school completed 0.020 
High school graduate or less 85  
Some college or technical school or higher 15  
Employment Status   
Homemaker 50  
Employed (includes Self-employed) 46  
Unemployed (but want to work) 3  
Student 1  
Health insurance  0.016 
No 65  
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Yes 35  
Knowledge level about HPV and HPV vaccination (N=98) 
Poor 52  
Good 48  
*P-Value of the association between demographic characteristics of the mother and the level of knowledge of 
participants (poor or good) 
 
From total mothers participating in the study, 35 had at least one daughter in the age range 9-18, 
35 had at least one son and, 30 had at least one daughter and one son in this age range. 
Vaccination status of adolescents reported by mothers 
From all mothers, only 36% of them indicated that their oldest adolescent in the age range 9-18 
years old, girl or boy, had at least 1 dose of the HPV vaccine series. From the participants that 
had at least one daughter in the age range 9-18 (N=65), only 33.8% had given at least one dose 
of the HPV vaccine to their daughters. Similarly, among mothers that had at least one son in the 
age range 9-18 (N=65), only 29.2% have given at least one dose of the HPV vaccine to their 
sons.  
Chi-square tests were computed to understand the relationship between demographic 
characteristics of the mothers and the vaccination status of children (at least one dose of the HPV 
vaccine series was given to the oldest son/daughter in the range age 9-18 or no vaccine has 
given). The level of education of the mother and their marital status were statistically significant 
associated to the vaccination status of their children χ2 (1, N=100) = 4.85, p = .02, χ2 (1, N=100) 
= 4.78, p = .029. Specifically, mothers with low education level and without a partner are less 
likely to vaccinate their children against HPV.  
Mothers’ experience in receiving medical care for themselves and their children 
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Most of the participants indicated that they were satisfied with the medical care received from 
their health care providers (83%), their doctors treat their children in a very friendly and 
courteous manner (95%) and they trust their child/children’s health care provider (83.8%).  
Participants also reported that medical providers were good about explaining the reason for 
vaccination (65%). However, a large percentage indicated that sometimes doctors use medical 
terms without explaining what they mean (61%). 
General knowledge of HPV and HPV vaccination 
The knowledge of the HPV/HPV vaccination among participants was low even though 86% 
indicated that they had heard of HPV and 76% indicated that they had heard about the HPV 
vaccine.  Regarding the HPV/HPV vaccination knowledge index, the average score obtained 
among the respondents was 7 (range 0-15).  The 52% of participants had poor HPV and HPV 
vaccination knowledge and 48% had good knowledge. Table 2 shows the percentage of correct 
answers to the questions assessing knowledge of the HPV/HPV vaccination and its association 
with the vaccination status of the children. The question asking about how HPV infection can be 
prevented had six answer options from which three were correct answers. Only 22% of the 
participants selected all three correct answers: 1. By practicing abstinence, 2. By using condoms 
and 3. By being vaccinated. Two correct answers were selected by 29% of the participants. One 
correct answer was selected by 24% of the participants. Lastly, 25% indicated that they did not 
know the answer or selected a wrong answer.  
Chi-square tests were computed to assess the association between demographic characteristics of 
the mothers and their knowledge about HPV and HPV vaccination. The mothers’ level of 
education and health insurance status were statistically significant associated to HPV/HPV 
vaccine knowledge (good or poor) χ2 (1, N=98) = 5.4, p = .02 and χ2 (1, N=98) = 5.8, p = .016 
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(Table 1). Specifically, mothers with low education and without health insurance were more 
likely to report low levels of HPV/HPV vaccination. 
The participants’ level of education was associated with both the knowledge that HPV affects 
only females and that HPV is curable, χ2 (2, N=100) = 7.8, p = .02 and χ2 (2, N=99) = 18.8, p 
<.01. Specifically, mothers with higher education (High School or higher) were more likely to 
report that HPV affects not only females and that there is not a cure for HPV. Similarly, 
education level was associated with having the son or daughter vaccinated with at least 1 dose of 
the HPV vaccine χ2 (1, N=100) = 4.8, p = .02.  Additionally, mothers with lower education 
levels were found more likely to vaccinate their children to prevent a common cold if there were 
a vaccine for it χ2 (2, N=100) = 8.4, p = .015.  
Table 2. Distribution of the HPV and HPV knowledge of Mexican mothers living in the 
Midwest of the US (N=100, otherwise noted) 
Correct answer % P-value 
HPV affects not only females 46 <.0001 
HPV is spread by sexual contact 67 0.0092 
HPV can cause cervical cancer 62 0.0002 
HPV is not a rare infection (N=99) 37.8 0.0056 
There is not a cure for HPV (N=99) 23.2 0.4182 
HPV can cause genital warts 42 0.0131 
HPV can cause cancer of the penis 20 0.3485 
HPV do not cause HIV 28 0.0689 
HPV cannot be detected by pap smears 3 0.0442 
The vaccine is recommended to girls at ages 9-26  52 0.0088 
The vaccine is recommended to boys at ages 9–26 43 0.1385 
More than one injection is needed for the HPV vaccine 38 <.0001 
Most medical plans and coupons cover the HPV vaccine 35 <.0001 
HPV vaccine is expensive 9 0.4825 
How HPV is transmitted by genital skin-to-skin contact 51 0.0531 
HPV infection be prevented by practicing abstinence, using condoms and 
being vaccinated 
22 0.0402 
 
   
*P-Value of the association between demographic characteristics of the mother and the vaccine status of their 
children. Chi-square or Fisher exact test were used. 
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Mothers’ awareness about vaccines and HPV vaccines 
From total participants, 76% have heard of the HPV vaccination. The 90% of mothers that had 
heard about the HPV vaccine heard about it from their medical provider. The 59% of participants 
had heard about the HPV vaccine on radio or T.V. Other sources include: friends, relatives and 
school. These three sources were selected by 43%, 39% and 34% of the participants, 
respectively. Some mothers heard about the HPV vaccine from more than one source. From 
those that had heard of the HPV vaccine (N=76), 33.3% indicated one source of information, 
21.3% have heard about it from two sources, 18.7% from three sources, 18.7% from four sources 
and only 8% of the mothers that have heard about HPV vaccine heard about it from the five 
sources indicated above. 
Chi-square tests were computed to understand the relationship between demographic 
characteristics of the mothers and the awareness about the HPV vaccine. Marital Status and 
health insurance status were the demographic characteristics that were statistically significant 
associated to the awareness of the HPV vaccine among mothers χ2 (1, N=100) = 9.2, p = .002, χ2 
(1, N=100) = 5.2, p = .021. Specifically, mothers that were married were more likely to know 
about the existence of the HPV vaccine.  Most of the mothers that indicated not being aware of 
the HPV vaccine did not have health insurance.  
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Figure 1. Sources of information about HPV vaccine reported among those participants 
that have heard previously about the vaccine (N=76) 
 
Mothers’ beliefs about vaccines and HPV vaccines 
Most participants believed vaccines, in general, are beneficial and that vaccinating their children 
against infections diseases is important (94%). Additionally, 97% of the mothers indicated 
wanting to vaccinate their children if the vaccine prevented cancer.  A 71% noted that HPV 
vaccines are beneficial. However, only 41% indicated that HPV vaccines are appropriate for 
children 9-12 years of age. A 48% of participants reported the HPV vaccine to be appropriate for 
not only girls. Only 37% of the mothers believe the HPV vaccine to be safe and 21% indicated 
prevention in vaccinating their children due to potential side effects of the HPV vaccine. 
Detailed information about the mothers’ responses are shown in Table 3. 
 
 
 
 
59%
90%
39%
43%
34%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Radio or T.V Medical provider Relatives Friends School
%
 o
f 
p
ar
ti
ci
p
an
ts
Source of information
21 
 
Table 3. Distribution of mothers’ beliefs about vaccines  
Statement % 
Vaccines (in general) are beneficial  94 
Vaccinating my children against diseases that can be spread person-to-person is important  94 
If there was a vaccine that prevented the common cold, I would want my children to get 
vaccinated  78 
If there were a vaccine that prevented cancer, I would want my children to get vaccinated  97 
I believe that vaccines should be required for diseases that can be spread person-to-person  78 
HPV vaccines are beneficial  71 
HPV vaccines are appropriate for adolescents (girls and boys as young as ages 9-12)  41 
HPV vaccines are appropriate just for girls   13 
HPV vaccine is safe  37 
Potential side effects of the HPV vaccine would prevent me from getting my child/children 
vaccinated   21 
HPV vaccine is difficult to get  2 
HPV vaccine causes health problems  8 
 
Logistic regression model predicting mothers’ willingness to vaccinate their children 
against HPV. 
A logistic regression model (LRM) was conducted to examine the association between the 
response variable ‘children received at least one dose of the HPV vaccine’ and four covariates. 
The response variable indicates if the oldest son or daughter was or not vaccinated with at least 
one dose of the HPV vaccine series. The covariates included: the length of time in the USA, the 
age of the mother, health insurance status, HPV/HPV Vaccination Knowledge and level of 
education of the mother. The model indicated that HPV/HPV Vaccination Knowledge among 
mothers was a significant predictor of their willingness to vaccinate against the HPV their 
adolescents (Table 4). According to the model, the odds of a mother getting their adolescent 
vaccinated against HPV is higher for mothers with good HPV/HPV vaccination knowledge OR: 
13.8, p<0.01. Specifically, a mother with good HPV/HPV vaccination knowledge has 13.8 times 
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the odds to vaccinate their children than a mother with a poor HPV/HPV vaccination knowledge.  
Hosmer-Lemeshow goodness of fit test indicated no significant lack of fit as p= 0.36 (>.05).   
Table 4. Logistic Regression Model predicting mothers’ willingness to vaccinate their 
children against HPV. 
  95% C.I. for OR P-Value 
Variable Odds Ratio Lower Upper  
Level of HPV Knowledge 13.851 4.638 41.366  <.0001 
Marital Status  5.483 1.144 26.282 0.0333 
TimeInUSA(Years) 1.075 0.993 1.165 0.0729 
 
Final model  
  95% C.I. for OR P-Value 
Variable Odds Ratio Lower Upper  
Level of HPV Knowledge 13.235 4.683 37.410 <.0001 
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Discussion and recommendations 
Results from this study are consistent with previous studies. Low levels of knowledge found, in 
average 8 points out of 19 possible points suggest a need to improve public health programs with 
information to promote the HPV vaccination among Latinos in Midwest of the US. This 
information should be tailored to the specific audience by providing it at an appropriate reading 
level and a culturally sensitive way to increase the level of knowledge about the HPV and its 
vaccine. 
Two equal groups of mothers were possible, one group with at least one daughter (N=65) and 
another group with at least one son (N=65), both having a child in the 9-18 years old range.  
Male vaccination of at least one HPV vaccine dose was found at 29.2% compared to 33.8% of 
female vaccination of at least one HPV vaccine dose, agreeing with a gender gap in HPV 
vaccination rates. Given that the mothers’ interest in vaccinating their boys against HPV was 
lower than mothers interest in given the vaccine to their girls, a gender-neutral approach when 
developing HPV prevention programs is necessary. The HPV vaccination for boys is critical for 
reducing the risk of HPV transmission to sexual partners and decreasing the risk of HPV and 
HPV-related diseases in the population. 
Due to the importance of the HPV infection prevention efforts, there is a large need for more 
reliable measures to estimate the Hispanic/Latino mothers’ level of knowledge, awareness and 
beliefs about the HPV/HPV vaccination. These estimates are an essential tool for guiding 
educational efforts among Latinos, the largest minority group in the US with the highest cervical 
cancer rates. 
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Results from the present study suggest a need for increasing public health education among 
Mexican mothers in the Midwest on HPV/HPV vaccination and its association with cancers in 
males and females.  
Policies from the state should support vaccination in school settings to improve HPV vaccination 
rates.  Schools should include more education on public health topics that involve students’ 
health to deliver it in an appropriate language to parents of Hispanic origin. Subjects such as the 
HPV and the importance of vaccination against HPV should be something that schools could 
promote even if they do not require HPV vaccination for their students.  
Engage the Mexican Consulate through the Health Window in disseminating more information 
about HPV/HPV vaccination. 
Findings suggest the importance of increasing awareness about the benefits of the HPV vaccine 
among Mexican mothers. Results indicated that schools are not the main source of information 
about HPV/HPC vaccination. Since schools play an important role in disseminating information 
among parents, it is suggested to improve cooperation between schools and health offices in 
order to increase rates of vaccination among Mexicans in the Midwest of the US. 
Future studies 
An assessment of knowledge about HPV/HPV vaccination and another cancer-related viruses 
among Hispanic/Latina Promotoras de Salud (lay health workers) in OneWorld Community 
Health Centers could be conducted. In addition, potential training programs according to results 
obtained could be implemented. 
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Most of the mothers indicated lack of medical insurance. However, some of them reported that 
their son(s)/daughters(s) had access to Medicaid when asked if they received benefits from 
government assistance programs. Future studies should be more emphatic in asking mothers if 
their children have medical insurance. Knowledge of health insurance status may improve 
conclusions regarding the association between children’s health insurance and being vaccinated 
against HPV. 
Even though this study did not analyze the level of English proficiency among participants, some 
respondents indicated that language might be a barrier when communicating with their medical 
providers. Additionally, participants mentioned the limited time of medical appointments making 
it difficult to receive education on topics such as ETS, including HPV.  Future related research 
should emphasize the English level of participants to assess its relationship with the knowledge 
about HPV/HPV vaccination among Mexican mothers.   
The inclusion criteria for a similar study should include people with at least a year of living in 
the US to better understand their experience regarding medical services and health education in 
the US. 
Strengths and Limitations 
Strenghts 
 The site was appropriate for recruitment of participants due to a high number of 
Mexicans that visit the Mexican consulate every day and that are living currently in 
different regions of Nebraska and neighboring states. 
 The method used to conduct the surveys allows data collection quality: 
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o Due to the long-time people have to wait for their turn at the Mexican consulate, 
they use their time in other activities such as visiting the Health window. 
o Time was not an issue for conducting an interview, in fact, they indicated to be 
comfortable by being assisted than filling out the questionnaire by themselves. 
o There was extra time for providing Health education on the topic to the 
participating mothers. 
 The study minimized bias by using a recruitment site not related to a health care 
institution which would be more likely to have access to participants already vaccinated; 
allowing the group of obtained participants to be very diverse. 
 
Limitations 
 
 This study was limited by a small sample size and the restriction of sampling to the 
Midwest US, prevents results to be generalized.  
 Since people are waiting for several hours to obtain services at the Mexican Consulate, 
additional education and information in different areas is provided, leading to a possible 
refusal to participate in the study due to participants’ being overwhelmed by all the 
activities in the site.  
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Service Learning/Capstone Experience Reflection  
OneWorld Community Health Centers is a community organization that provides culturally 
respectful, quality health care with special attention to the underserved. I have learned that it 
provides accessible health services to the community, and the Latino community Omaha is one of 
the most benefited from this. OneWorld collaborates with the Mexican Consulate through the 
Health Window that is located in its installations. 
Through the Health Window located at the Mexican Consulate, OneWorld helps the community 
served by the Mexican Consulate by identifying the health services they and their family need in the 
US. Through this service, it is possible to refer community members to the health services available 
where they live and also provide them with information and education on a variety of health topics. 
The primary goals of the Health Window are to help prevent diseases, promote healthy habits and to 
refer families to health services, like those offered by community clinics where they can establish a 
medical home and receive the health care that they need. Some basic health screenings are 
conducted in the Health Window such as the measurement of the BMI, the glucose level, and the 
blood pressure. Results of these tests are accompanied with health education. 
It is known that the best way to learn about a topic is to explain it to others, and it is what exactly I 
was able to do during my Service Learning and Capstone Experience in the Health Window. Due to 
the installations and population served in this place, services are mainly focused on health 
education. I had the opportunity to contribute to the public health of the community served by the 
Mexican Consulate that comes from Nebraska and neighboring states in the following topics: 
 
 Vaccination in general 
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 HPV and HPV vaccination 
 Nutrition  
 Physical activity 
 Obesity prevention 
 Chronic diseases 
 Zika virus 
My Service Learning included daily activities such as informing the Mexican consulate users about 
the free health services that OneWorld offers at the Health Window as well as inviting them to use 
these services. People that were interested were asked if they wanted their glucose level, blood 
pressure and the Body Mass Index (BMI) measured. After completing these tests, depending upon 
the results, I supported the Health Window personnel by providing education in the areas needed as 
well as recommending them to a community health center in case any test results were not in the 
desired range. This way, health education provided varied from user to user depending on their 
specific needs. Additionally, twice a week the Mexican consulate provided the Health Window with 
a space to provide public presentations about a health topic of interest. I participated by providing 
presentations in Spanish about vaccines in general and the Zika virus. 
 
Furthermore, I was able to recruit participants for the study that was funded by the Cancer 
Epidemiology Education in Special Populations (CEESP) program. The recruitment consisted of 
100 interviews applying a 76-item bilingual questionnaire in the language of preference of 
participants. The informed consent was applied verbally before starting each interview, and at the 
end of the survey, I provided health education on HPV and HPV vaccination to Mexican mothers as 
well as a gift card to thank them for their participation. 
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The recruitment of participants started on June 19, and after two days of data collection, I realized 
that a lot of users of the Mexican consulate are from neighboring states of Nebraska and my initial 
inclusion criteria included only participants living in Nebraska.  I met with my advisor who advised 
me on amending the IRB on the inclusion criteria to include people from not just Nebraska but 
neighboring states to improve the chances to recruit the sample size of the pilot study. 
The Service Learning and Capstone Experience improved my understanding of how a research 
project needs to be planned and executed and the obstacles that might be overcome for a successful 
completion. I completed an IRB protocol as a principal investigator and designed a structured 
bilingual questionnaire based on literature review with help from Dr. Armando de Alba, the staff 
member of the committee and Mariela Bahena, a CEESP fellow conducting a similar study in 
Veracruz, Mexico. I recruited participants, delivered accurate health education using CDC resources 
and analyzed the data obtained. A manuscript for publication was prepared. 
I started communications with the preceptor of the SL/CE months before starting my Service 
Learning, and it was helpful for keeping the project working. Even so, some delays were 
experienced, and it affected the timeline of my project. Even though the UNMC and One World had 
a previous affiliation agreement, the greatest challenge that I faced during my SL/CE was related to 
paperwork and communication with directives of both One World and the Mexican Consulate to get 
specific permissions to start the project. In my opinion, the constant communication with all parts 
involved in the research project including the site representatives, the UNMC SL/CE administrator, 
members of the SL/CE committee as well as the IRB administrators is critical. 
After completing the Service Learning, I had the opportunity to present preliminary results to the 
CEESP committee and the SL/ CE committee and obtained feedback to work in the final SL/CE 
report and prepare a manuscript for publication. Meetings with the SL/ CE committee members for 
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follow-up on the results of the research project and manuscript preparation for publication were 
essential for the completion of the SL and CE.  
In conclusion, the SL/CE reaffirmed my skills in working with communities and being able to 
participate in supporting the Health Window activities strengthened my skills in community 
health education. Additionally, my language and cultural background are assets that helped me to 
be closer to the Mexican community learning from their culture as well as being able to support 
the health activities promoted by the Health Window at the Mexican consulate. I have also been 
strengthening my skills in study design and in creating instruments for data collection as well as 
developing the recruitment of participants in a successful way.  In the process of generating the 
final report, I used SPSS software package for data management, statistical analyses, and data 
presentation. I applied statistical knowledge to perform data analysis, and I improved my 
analytic skills as well as scientific writing. 
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Appendices 
Appendix 1. Questionnaire used for the research project. 
ASSESSMENT OF KNOWLEDGE AND BELIEFS ABOUT HPV VACCINATION AMONG 
MOTHERS OF MEXICAN ORIGIN IN NEBRASKA AND NEIGHBORING STATES (IRB#331-
17-EP) 
 
 
1. Zip code: ______________ 
 
2. What is your age? ____________ 
 
3. In what part of Mexico were you born?  State _____________ 
4. Including yourself, how many people live in your household? ___________   
 
5. What is your current marital status? 
1  Married  
2  Single 
3  Cohabiting 
 
 
4  Widowed  
5  Separated 
 
6. If married or partnered, in what country was your partner born? 
1  US  
2  Mexico 
3  Guatemala 
4  El Salvador 
5  Other (Indicate)__________________
 
7. How old were you when you immigrated to the US?  ____________ 
 
8. How long have you lived in the US?  ______ months _______ years 
 
9. How long have you lived in Nebraska?  _______months    ______years 
 
10. What is the highest grade or year of school you completed? 
1  Never attended school 
2  Elementary school (Grades 1-6) 
3  Middle School (Grades 7-9) 
4  Some High school  
 
5  High school graduate or GED 
6  Some college or technical school 
7  College graduate  
 
11. Are you? 
1  Employed (Full-time) 
2  Employed (Part-time, but want to work full-
time) 
3  Employed (Part-time by choice) 
4  Self-employed (ex. informal work) 
5  Unemployed, but want to work  
6  Unemployed by choice 
7  Student 
8  Homemaker 
9  Retired 
 
 
12. Do you have any kind of health insurance? 
Part A. Demographic characteristics of the mother 
 37 
 
 
1  Yes 
0  No  
2  Don’t Know 
 
13. If you answered yes to the question above, what kind of health insurance do you have? 
1  Private health insurance plan (BlueCross BlueShield) 
2  Federal coverage programs (Medicaid, Medicare, CHIP) 
3  VA (Veterans Health Administration) 
 
 
14. Which of the following government assistance programs do you have? 
 
1  SNAP (food stamps) 
2  Vaccines for Children program (VFC) 
3  Other (Indicate)____________________ 
4  None 
 
 
15. How many sons 9-18 years old do you have living with you? ___________  
 
16. How many daughters 9-18 years old do you have living with you? __________ 
 
Please answer the following questions about yourself or your oldest son and/or daughter between the ages of 9-18. 
 
Part C. Mothers’s experience in receiving medical care for themselves and their children  
 
 Yes No 
17.  Please, think of the last time that you received medical care. Did you feel 
that the doctor needed to be more thorough in treating and examining you?   
18. Please, think of the last time that your child received medical care. Did you 
feel that the doctor needed to be more thorough in treating and examining 
your child?   
19. Please, think of the last time that you received medical care. Were you very 
satisfied with the medical care you received?   
 
 
Strongly Agree 
1 
Agree 
2 
Neutral 
3 
Disagree 
4 
Strongly Disagree 
5 
20. In general, I feel that doctors are 
good about explaining the reason 
for vaccines 
     
21. In general, sometimes doctors 
use medical terms without 
explaining what they mean  
     
22. My doctors treat my 
child/children in a very friendly 
and courteous manner 
     
23. I trust my child/children’s health 
care provider 
     
Part B. Demographic characteristics of child/children 
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Part D. Knowledge and beliefs about HPV and vaccines 
 
General knowledge of HPV and HPV vaccine 
 
Statements about HPV Yes No I don’t 
know 
24. I have previously heard of HPV (Human Papillomavirus)?    
25. HPV (Human Papillomavirus) affects only females    
26. HPV (Human Papillomavirus) is spread by sexual contact    
27. HPV (Human Papillomavirus) can cause cervical cancer    
28. HPV (Human Papillomavirus) is a rare infection    
29. There is a cure for HPV (Human Papillomavirus)    
30. HPV (Human Papillomavirus) can cause genital warts    
31. HPV (Human Papillomavirus) can cause cancer of the penis    
32. HPV (Human Papillomavirus) can cause HIV    
33. HPV (Human Papillomavirus) can be detected by pap smears    
34. The vaccine is recommended to girls at ages 11 & 12 but it can also 
be given between the ages of 9–26    
35. The vaccine is recommended to boys at ages 11 & 12 but it can also 
be given between the ages of 9–26    
36. Only one injection is needed for the HPV vaccine    
37. Most medical plans and coupons cover the HPV vaccine    
38. HPV vaccine is expensive    
 
39. How do you think HPV (Human Papillomavirus) is transmitted or spread? 
 
1  Coughing or sneezing 
2  Genital skin-to-skin contact 
3  Contact with bodily fluids (blood) 
4  I don’t know 
 
40. How can HPV (Human Papillomavirus) infection be prevented? (Please select all that apply.) 
 
1  By practicing abstinence 
2  By taking antibiotics 
3  By using condoms 
4  By being vaccinated 
5  I don’t know 
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HPV vaccine awareness  
 Yes No I don’t 
know 
41. I have heard of the cervical cancer vaccine, also known as 
the HPV (human papillomavirus) vaccine or Gardasil 
   
42. I have heard of the HPV (human papillomavirus) vaccine 
on the radio or television 
   
43. I have heard of the HPV (human papillomavirus) vaccine 
from medical providers 
   
44. I have heard of the HPV (human papillomavirus) vaccine 
from relatives 
   
45. I have heard of the HPV (human papillomavirus) vaccine 
from friends 
   
46. I have heard of the HPV (human papillomavirus) vaccine 
from school (child’s school) 
   
 
Personal experience with HPV vaccine  
 Yes No I don’t 
know 
47. The HPV (human papillomavirus) vaccine has been offered 
to my daughter 
   
48. The HPV (human papillomavirus) vaccine has been offered 
to my son 
   
49. I am planning to give the HPV (human papillomavirus) 
vaccine to my daughter 
   
50. I am planning to give the HPV (human papillomavirus) 
vaccine to my son 
   
 
Vaccine beliefs  
 Yes No I don’t 
know 
51. Vaccines (in general) are beneficial    
52. Vaccines (in general) are unnecessary    
53. Vaccinating my children against diseases that can be spread 
person-to-person is important    
54. If there was a vaccine that prevented the common cold, I 
would want my children to get vaccinated    
55. If there were a vaccine that prevented cancer, I would want 
my children to get vaccinated    
56. I believe that vaccines should be required for diseases that 
can be spread person-to-person    
57. HPV (human papillomavirus) vaccines are beneficial    
58. HPV (human papillomavirus) vaccines are appropriate for 
adolescents (girls and boys as young as ages 9-12)    
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59. HPV (human papillomavirus) vaccines are appropriate just 
for girls     
60. HPV (human papillomavirus) vaccine is safe    
61. Potential side effects of the HPV (human papillomavirus) 
vaccine would prevent me from getting my child/children 
vaccinated against HPV (human papillomavirus)    
62. HPV (human papillomavirus) vaccine is difficult to get    
63. HPV vaccine causes health problems    
 
 
Beliefs about adverse behavioral consequences of HPV vaccination  
Vaccinating my children would send a message that: 
 
 
Strongly Agree 
1 
Agree 
2 
Neutral 
3 
Disagree 
4 
Strongly Disagree 
5 
64. It is okay to have 
sex 
     
65. She/he doesn't have 
to use safe sex 
practices 
 
 
 
 
 
 
 
 
 
 
 
Information regarding your oldest son in the 9–18 years age range   
 
66. Age __________________ 
 
 Yes No I don’t 
know 
67. Has your son started (but not completed) the HPV (human 
papillomavirus) vaccine series? 
   
68. Has your son completed the HPV (human papillomavirus) vaccine 
series? 
   
69. Does your son have an appointment to receive the HPV (human 
papillomavirus) vaccine? 
   
70. Has your son not received any doses of HPV (human papillomavirus) 
vaccine? 
   
 
Information regarding your oldest daughter in the 9–18 years age range 
 
71. Age____________________ 
 
 Yes No I don’t know 
72. Has your daughter started (but not completed) the HPV 
(human papillomavirus) vaccine series? 
   
73. Has your daughter completed the HPV (human 
papillomavirus) vaccine series? 
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74. Does your daughter have an appointment to receive the HPV 
(human papillomavirus) vaccine?  
    
75. Has your daughter not received any doses of HPV (human 
papillomavirus) vaccine? 
   
 
76. If your child/children are not vaccinated against HPV, what is the reason your child did not get the 
vaccine? 
 
1  Concern over side-effects 
2  Costs 
3  Not enough information to make decision 
4  Not offered 
5  Concerns about sexual practices 
6  Other (Indicate)___________________ 
 
